
Kintara Therapeutics
Engaged in developing and commercializing therapies for the treatment of cancer patients.
Market cap
$12.0m
Enterprise value
$17m
Share price
$2.81 KTRA
Authorizing premium user...
Engaged in developing and commercializing therapies for the treatment of cancer patients.